MEDELLIN, Colombia & TORONTO--(BUSINESS WIRE)--FCM Global S.A.S. (“FCM”), a pioneer within Colombia in the use of cannabinoids and terpenes for medicinal purposes, has become the first licensed Colombian producer to offer a premium quality full spectrum cannabis extract for distribution to legal markets worldwide. FCM’s VerdeCann Full Spectrum extract is rich in CBD, low in THC, and contains all the active cannabinoids, terpenes, fatty acids, flavonoids, vitamins, and minerals from the natural plant.
FCM’s advanced genetics, organic farming methods, enclosed natural sunlight greenhouses, and high-capacity ethanol extraction technology enable VerdeCann Full-Spectrum to be offered under US $2.00 per gram. Designed to meet the growing global demand for a lower-cost full spectrum extract that does not compromise consistency or quality, VerdeCann Full Spectrum will commence shipping at industrial volumes in April.
Dr. Juan Carlos Restrepo, Chief Science Officer of FCM, said: “Formulated by FCM’s Colombian in-house scientific team, VerdeCann Full Spectrum helps us deliver on our Co-Sourced Colombia model, designed to pass on Colombia’s lower costs of production to our Client-Partners while providing them a scalable source of world-class cannabis extracts.”
Carlos Velasquez, CEO and co-founder of FCM, adds: “FCM is proud to be Colombia’s first supplier of full spectrum medical cannabis extracts for domestic and international markets. This represents another operational milestone for our company as we aim to provide value-added support for our Client-Partners’ innovative finished products and advancements in whole plant related therapies.”
About FCM Global S.A.S.
FCM Global S.A.S. is a Colombian-founded integrated medical cannabis platform company with headquarters in Medellin, operations in La Ceja, and a distribution office in Toronto, Canada. FCM provides pharmaceutical, nutritional, and cosmetic companies in legal medical cannabis markets worldwide with custom extracts, oils, and isolates, as well as R&D advisory services focused on evidence-based clinical studies. FCM was Colombia’s first fully-licensed producer and exporter of non-psychoactive (<1% THC) CBD cannabis extracts for medical and research purposes and is currently in the process of receiving its psychoactive THC license. Each member of the FCM team possesses deep experience in Colombia and understands the importance of giving back to the local communities in which they live and work.